Human TWEAK R/TNFRSF12 Antibody

Catalog #: AF1199
2 Citations Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
AF1199
AF1199-SP

SAVE +FREE SHIPPING with ACADEMIA23 (See Promo Details)

TWEAK R/TNFRSF12 Inhibition of TWEAK/TNFSF12-depend-ent Cell Proliferation and Neutralization by Human TWEAK R/TNFRSF12 Anti-body.

1 Image

View All Products for TWEAK R/TNFRSF12

Product Details

Citations (2)

Supplemental Products

Reviews

Summary Data Examples Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Human TWEAK R/TNFRSF12 Antibody Summary

Species Reactivity

Human

Specificity

Detects human TWEAK R/TNFRSF12 in direct ELISAs and Western blots. In direct ELISAs, approximately 80% cross-reactivity with recombinant mouse TWEAK R/TNFRSF12 is observed.

Source

Polyclonal Goat IgG

Purification

Antigen Affinity-purified

Immunogen

recombinant human TWEAK R/TNFRSF12
Glu28-Trp79
Accession # Q9NP84

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Endotoxin Level

<0.10 EU per 1 μg of the antibody by the LAL method.

Applications

Recommended Concentration

Sample

Western Blot

0.1 µg/mL

Recombinant Human TWEAK R/TNFRSF12 Fc Chimera (Catalog # 1199-TW)

Immunohistochemistry

5-15 µg/mL

Immersion fixed paraffin-embedded sections of human liver cancer tissue

Neutralization

Measured by its ability to neutralize TWEAK R/TNFRSF12-mediated inhibition of proliferation in HUVEC human umbilical vein endothelial cells. The Neutralization Dose (ND₅₀) is typically 0.3-1.2 µg/mL in the presence of 30 ng/mL Recombinant Human TWEAK R/TNFRSF12 Fc Chimera and 20 ng/mL Recombinant Human TWEAK/TNFSF12.

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Neutralization

View Larger

TWEAK R/TNFRSF12 Inhibition of TWEAK/TNFSF12-depend-ent Cell Proliferation and Neutralization by Human TWEAK R/TNFRSF12 Anti-body. Recombinant Human TWEAK R/TNFRSF12 Fc Chimera (Catalog # 1199-TW) inhibits Recombinant Human TWEAK/TNFSF12 (Catalog # 1090-TW) induced proliferation in HUVEC human umbilical vein endothelial cells in a dose-dependent manner (orange line). Inhibition of Recombinant Human TWEAK/TNFSF12 (20 ng/mL) activity elicited by Recombinant Human TWEAK R/TNFRSF12 Fc Chimera (30 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human TWEAK R/TNFRSF12 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1199). The ND₅₀ is typically 0.3-1.2 µg/mL.

Reconstitution Calculator

Preparation and Storage

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS.

Reconstitution Buffer Available

Reconstitution Buffer 1 (PBS)

Shipping

The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: TWEAK R/TNFRSF12

The gene for TNF-related weak inducer of apoptosis receptor (TWEAK R) was originally identified as a fibroblast growth factor-inducible immediate-early response gene Fn14 in mouse NIH 3T3 fibroblasts (1, 2). Human TWEAK R cDNA encodes a 129 amino acid (aa) residue type I transmembrane protein with a 27 aa signal peptide, a 53 aa extracellular domain, a 21 aa transmembrane domain and a 28 aa cytoplasmic domain (1‑3). Human and mouse TWEAK R share 82% aa sequence identity. TWEAK R is the smallest member of the TNF receptor superfamily and contains only one cysteine-rich region in its extracellular domain. The TWEAK R cytoplasmic domain conatins one TRAF binding motif which binds TRAFs 1, 2, and 3. TWEAK R binds its ligand TWEAK/TNFSF12 with high affinity to initiate a signal transduction cascade that depending upon the cell type, may lead to a variety of cellular responses including cell death, cell proliferation, and angiogenesis (2‑6). In new born mice, TWEAK R is highly expressed in all tissues examined (heart, intestine, kidney, liver, lung and skin) (1). In adult mice, high TWEAK R expression levels are found in the heart and ovary, while lower expression levels are detected in the lung, kidney, skin. Elevated levels of TWEAK R mRNA were found in human or mouse hepatocellular carcinoma specimens, in regenerating mouse liver and in injured rat arteries (2, 3).

References

Meighan-Mantha, R. et al. (1999) J. Biol. Chem. 274:33166.
Feng, S. et al. (2000) Am J. Pathol. 156:1253.
Wiley, S. et al. (2001) Immunity 15:837.
Schneider, P. et al. (1999) Eur. J. Immunol. 29:1785.
Nakayama, M. et al. (2002) J. Immunol. 168:734.
Lynch, C.N. et al. (1999) J. Biol. Chem. 274:8455.

Long Name

TNF-like and Weak Inducer of Apoptosis Receptor

Entrez Gene IDs

51330 (Human); 27279 (Mouse)

Alternate Names

CD266 antigen; CD266; FGF-inducible 14; Fibroblast growth factor-inducible immediate-early response protein 14; Fn14; FN14tumor necrosis factor receptor superfamily member 12A; TNFRSF12; TNFRSF12A; tumor necrosis factor receptor superfamily, member 12A; TWEAK R; TWEAKR; tweak-receptor; type I transmembrane protein Fn14

Product Datasheets

Product Datasheet

COA

SDS

Related Research Areas

Citations for Human TWEAK R/TNFRSF12 Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

2 Citations: Showing 1 - 2
Filter your results:

Filter by:

TWEAK/Fn14 system and crescent formation in IgA nephropathy.
Authors: Sasaki Y, Shimizu Y, Suzuki Y, Horikoshi S, Tomino Y
BMC Nephrol, 2015-03-14;16(0):27.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-P
Lipocalin 2, the TNF-like receptor TWEAKR and its ligand TWEAK act downstream of NFAT1 to regulate breast cancer cell invasion.
Authors: Gaudineau B, Fougere M, Guaddachi F, Lemoine F, de la Grange P, Jauliac S
J Cell Sci, 2012-07-05;125(0):4475-86.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization